Athersys Inc. stem cell therapy for bowel disease fails to show ‘meaningful … – Crain’s Cleveland Business
| Crain’s Cleveland Business The results reflect patient data for eight weeks following cell therapy or placebo administration, Athersys said. Additional 16-week results, including data about the impact from a second round of dosing for a subset of patients, will be available … Athersys stem–cell therapy for bowel disease fails in studyReuters Athersys stem cell therapy disappoints in first efficacy trial in bowel …MedCity News Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy …Wall Street Journal Benzinga all 10 news articles |
